UCSF is the only site in California participating in a National Institutes of Health (NIH)–sponsored clinical trial designed to prevent cancer in people with Lynch syndrome. Lynch syndrome affects about 1 in 279 people in the U.S. and significantly increases the lifetime risk of colorectal cancer and several other cancers.